TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PEN

Penumbra Inc

Healthcare · Medical Devices

318.80$ +0.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+127.0% -7.5% -224.7% -685.8% +73.1% +41.7%
+133.3% +31.1% +64.6% +63.1% +27.3% +64.2% +51.2% +41.5% +11.0% -22.6% -26.3%
+407.4% +101.3% +21.7% +3.4% +16.6% +18.9% +157.5% -43.2% +35.1% -8.6% +28.3%
+118.5% +5.0% +182.8% +8.9% -247.0% +135.2% -23.8%
+40.8% +149.1% +10.2% -36.1% +130.2% +12.0% -14.4% -8.9% -21.2% +39.2% +200.9%
+131.9% -11,403.2% -99.5% +2,993.8% +774.4% -79.1% -129.3% -621.2%
-45.7% +57.3% -49.2%
-73.0% +3.9% +345.4% +51.7% +4.6% -45.7% +57.3% -49.2% -74.2% +4,740.3%
-82.0% +0.0% +0.0% -62.6% +536.1% +33.0% -57.5% +20.7% +13.1% +14.9% +9.2%
+190.1% -94.3% +1,364.5% -109.4% -0.6% -99.4% +1,290.2% +39.4% -637.0%
-138.8% -54.0% -71.4% -163.1% +831.7% +60.7% -187.6%
-76.3% -1,376.6% +79.4% +18.8%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?